50 Landmark Papers every Breast Surgeon Should Know

This book identifies 50 key scientific articles in the field of breast disease and surgery, examining their importance and impact. A valuable reference to the established surgeon, breast surgery residents and trainees.

There has been an exponential increase in the volume and quality of published research relating to breast disease over the past decades. This book identifies the 50 key scientific articles in the field of breast disease and breast surgery and examines their importance and impact on current clinical care.

Among thousands of articles, a small fraction are truly 'game changing'. Such studies form the foundations of breast surgery today, and the selection of papers within this book provide the 50 landmark papers every 21st-century breast surgeon needs to know. A commentary to each carefully selected paper explains why these papers are so important, thus providing every surgeon with the foundation stones of knowledge in this fast-moving area.

A valuable reference not only to the established surgeon, but also to breast surgery residents and trainees, as well as to more experienced surgeons as they continue to learn new techniques and approaches and to improve their knowledge of breast disease and treatments. The papers provide an evidence-based resource for those surgeons preparing for professional exams and may inspire clinicians to produce new research.

Autorentext

Lynda Wyld is Professor of Surgical Oncology at the University of Sheffield and a Consultant Oncoplastic Surgeon at Doncaster and Bassetlaw Teaching Hospitals. She is the Past President of the British Association of Surgical Oncology (BASO) and Past Chair of the European Society of Surgical Oncology (ESSO) Education Committee and is a Trustee of the Association of Breast Surgery (ABS).

Ramsey Cutress is Professor of Breast Surgery at University of Southampton and a Consultant Surgeon at University Hospital Southampton. He is Chair of the Association of Breast Surgery (ABS) Academic and Research Committee, Course Director for the ABS Advanced Skills in Breast Disease Management course, Head of the School for Clinical Academic Training at the Wessex Deanery and breast disease subspecialty editor for the Annals of the Royal College of Surgeons of England, demonstrating his interests in research and teaching.

Jenna Morgan Jenna is an NIHR Advanced Fellow Breast Surgery at the University of Sheffield and a Consultant Oncoplastic Surgeon at the Jasmine Breast Unit in Doncaster, UK. She is Past Chair of the Mammary Fold Academic Committee of the ABS. She is a clinical academic with an interest in mixed methods research, geriatric oncology and the psychology or ageing in healthcare settings.

Inhalt

Section One: Epidemiology

1. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

Collaborative Group on Hormonal Factors in Breast Cancer

2. Moderate Alcohol Intake and Cancer Incidence in Women

Allen N, Beral V, Cassabone D, Kan SW, Reeves GK, Brown A, Green J on behalf of the Million Women Study Collaborators

Section Two: Screening and Prevention

3. 3. Tamoxifen for Prevention of Breast Cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study (NASBP P-1)

Fisher B, Costantino J, Wickerman D, et al

4. 4. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.

Tabar L, Fagerberg G, Duffy SW, et al

5. 5. The benefits and harms of breast cancer screening: an independent review

Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M.

Section Three: Diagnostic Imaging

6. 6. Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening (DMIST)

Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D'Orsi C, Jong R, Rebner M

7. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)

Leach MO, Boggis CRM, Dixon AK, Easton DF, et al

8. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial

Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, Hanby A, Brown J

Section Four: Surgery: Mastectomy versus conservation

9. 9. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer

Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N

10. The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast Conserving Therapy: A Meta-Analysis

Houssami N, Macaskill P, Marinovich ML, Morrow M

11. Ten year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study

van Maaren MC, de Munck L, de Back GH, Jobsen J, van Dalen T, Poortmans P, Strobbe LC, Siesling S.

Section Five: De-escalation of Axillary Surgery

12. 12. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N

13.13. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women with Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Giuliano AE, Ballman KV, McCall L, et al.

14. 14. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Donker M, van Tienhoven G, Straver ME, et al

1515. Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

Boughey JC, Suman VJ, Mittendorf EA, et al.

Section Six: Oncoplastic Breast Surgery / Breast Reconstruction

16. 16. Planning and use of therapeutic mammaplasty-Nottingham approach

S J McCulley and R D Macmillan

17.17. Oncoplastic breast conserving surgery for women with primary breast cancer

Nanda A, Hu J, Hodgkinson S, Ali S, Rainsbury R, Roy PG.

18.18. Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study

Potter et al

19.19. Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery

Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM

Section Seven: Breast cancer genomics and prognostic tools

20.20. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Therese Sørlie, Charles M. Perou, Robert Tibshirani, Turid Aas, Stephanie Geisler, Hilde Johnsen, et al.

21.21. Comprehensive molecular portraits of human breast tumours

The cancer Genome Atlas Network

2222. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

Fatima Cardoso, Laura J. van't Veer, Jan Bogaerts, et al for the MINDACT investigators

23. 23. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer (RxPonder)

K. Kalinsky, W.E. Barlow, J.R. Gralow, et al

24.24. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer

Gordon C Wishart, Elizabeth M Azzato, David C Greenberg, Jem Rashbass, Olive Kearins, Gill Lawrence, Carlos Caldas, and Paul DP Pharoah

Section Eight: Ductal Carcinoma In Situ

25 25. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.

*Esther H. Lips, Tapsi Kumar, An…